342 related articles for article (PubMed ID: 37132530)
1. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
2. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
[TBL] [Abstract][Full Text] [Related]
3. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
4. [Phenotypic plasticity of neural crest-derived melanocytes and Schwann cells].
Dupin E
Biol Aujourdhui; 2011; 205(1):53-61. PubMed ID: 21501576
[TBL] [Abstract][Full Text] [Related]
5. De- and re-differentiation of the melanocytic lineage.
Larribere L; Utikal J
Eur J Cell Biol; 2014; 93(1-2):30-5. PubMed ID: 24365127
[TBL] [Abstract][Full Text] [Related]
6. From neural crest cells to melanocytes: cellular plasticity during development and beyond.
Vandamme N; Berx G
Cell Mol Life Sci; 2019 May; 76(10):1919-1934. PubMed ID: 30830237
[TBL] [Abstract][Full Text] [Related]
7. Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes.
Köhler C; Nittner D; Rambow F; Radaelli E; Stanchi F; Vandamme N; Baggiolini A; Sommer L; Berx G; van den Oord JJ; Gerhardt H; Blanpain C; Marine JC
Cell Stem Cell; 2017 Nov; 21(5):679-693.e6. PubMed ID: 29033351
[TBL] [Abstract][Full Text] [Related]
8. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
9. DHODH modulates transcriptional elongation in the neural crest and melanoma.
White RM; Cech J; Ratanasirintrawoot S; Lin CY; Rahl PB; Burke CJ; Langdon E; Tomlinson ML; Mosher J; Kaufman C; Chen F; Long HK; Kramer M; Datta S; Neuberg D; Granter S; Young RA; Morrison S; Wheeler GN; Zon LI
Nature; 2011 Mar; 471(7339):518-22. PubMed ID: 21430780
[TBL] [Abstract][Full Text] [Related]
10. The roles of Frizzled-3 and Wnt3a on melanocyte development: in vitro studies on neural crest cells and melanocyte precursor cell lines.
Chang CH; Tsai RK; Tsai MH; Lin YH; Hirobe T
J Dermatol Sci; 2014 Aug; 75(2):100-8. PubMed ID: 24815018
[TBL] [Abstract][Full Text] [Related]
11. Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion.
McConnell AM; Mito JK; Ablain J; Dang M; Formichella L; Fisher DE; Zon LI
Dev Biol; 2019 May; 449(2):107-114. PubMed ID: 29883661
[TBL] [Abstract][Full Text] [Related]
12. Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.
Mica Y; Lee G; Chambers SM; Tomishima MJ; Studer L
Cell Rep; 2013 Apr; 3(4):1140-52. PubMed ID: 23583175
[TBL] [Abstract][Full Text] [Related]
13. MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.
Heppt MV; Wang JX; Hristova DM; Wei Z; Li L; Evans B; Beqiri M; Zaman S; Zhang J; Irmler M; Berking C; Besch R; Beckers J; Rauscher FJ; Sturm RA; Fisher DE; Herlyn M; Fukunaga-Kalabis M
J Invest Dermatol; 2018 Jan; 138(1):141-149. PubMed ID: 28927893
[TBL] [Abstract][Full Text] [Related]
14. GNAQ
Urtatiz O; Cook C; Huang JL; Yeh I; Van Raamsdonk CD
Pigment Cell Melanoma Res; 2020 Jan; 33(1):96-111. PubMed ID: 31680437
[TBL] [Abstract][Full Text] [Related]
15. Generation of human melanocytes from induced pluripotent stem cells.
Ohta S; Imaizumi Y; Akamatsu W; Okano H; Kawakami Y
Methods Mol Biol; 2013; 989():193-215. PubMed ID: 23483397
[TBL] [Abstract][Full Text] [Related]
16. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
18. The melanocyte lineage in development and disease.
Mort RL; Jackson IJ; Patton EE
Development; 2015 Feb; 142(4):620-32. PubMed ID: 25670789
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide stress responses in neural crest cell fate and melanoma.
Sporrij A; Zon LI
Cell Cycle; 2021 Aug; 20(15):1455-1467. PubMed ID: 34281491
[TBL] [Abstract][Full Text] [Related]
20. Melanocytes, melanocyte stem cells, and melanoma stem cells.
Lang D; Mascarenhas JB; Shea CR
Clin Dermatol; 2013; 31(2):166-78. PubMed ID: 23438380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]